Well Done @lucyjhoward and @GauriSaini6 in Recruiting the Final Participant into IPF JES Study
Well Done @lucyjhoward and @GauriSaini6 in Recruiting the Final Participant into IPF JES Study
top of page
Search
Glenn Hearson
- Sep 6, 2018
NIHR Nottingham BRC Research; It’s Not JUST Idiopathic Pulmonary FibrosiS Study (INJUSTIS)
New NIHR Nottingham BRC Research; It’s Not JUST Idiopathic Pulmonary FibrosiS Study (INJUSTIS)
205
Glenn Hearson
- Jan 3, 2018
Celgene CC-90001-IPF-001Research Study
The Joint Respiratory Research Day will take place on 2nd May 2018 at Stamford Court, Leicester
459
Glenn Hearson
- Dec 8, 2017
The Efficacy and Mechanism Evaluation of Treating IPF with the addition of Co-trimoxazole
The Efficacy and Mechanism Evaluation of Treating IPF with the addition of Co-trimoxazole
155
Glenn Hearson
- Dec 8, 2017
Idiopathic Pulmonary Fibrosis Job Exposure Study (IPF JES)
IPF JES is a research study that aims to discover if workplaces are a cause of idiopathic pulmonary fibrosis (IPF). Dr Gauri Saini leading
94
Glenn Hearson
- Nov 7, 2016
Understanding the mechanisms of idiopathic pulmonary fibrosis in order to develop new treatments
IPF is a progressive and devastating lung disorder characterised by irreversible scarring (fibrosis) of the lung. IPF affects over 8,000 peo
60
Glenn Hearson
- Sep 4, 2016
Amplification of TGFβ Induced ITGB6 Gene Transcription May Promote Pulmonary Fibrosis
Idiopathic pulmonary fibrosis (IPF) is a devastating, progressive disease with poor survival rates and limited treatment options. Upregulati
20
Glenn Hearson
- May 28, 2016
Reduced Ets Domain-containing Protein Elk1 Promotes Pulmonary Fibrosis via Increased Integrin αvβ6
Idiopathic pulmonary fibrosis (IPF) is a progressive fibrotic lung disease with high mortality. Active TGFβ1 is considered central to the pa
12
bottom of page